VUL Santarose – TACE procedure with BioPearl microspheres

At VUL Santaros Klinikos , innovations in clinical practice are applied quickly, safely and responsibly.

The first transarterial chemoembolization (TACE) procedure was performed in this hospital using innovative Biopearl (Terumo) microspheres, the procedure was performed by the head of the radiology department Dr. Marius Kurminas.

During TACE treatment, chemotherapy drugs are delivered directly to the artery supplying the tumour, while blocking blood flow – thus limiting the tumour’s oxygen and nutrient supply. The unique advantage of BioPearl™ microspheres is the ability to reach the therapeutic area again, gradually restore blood circulation and reapply intraarterial treatment, which is relevant for repeated TACE procedures. Innovative treatment with BioPearl helps reduce the risk of secondary blood vessel formation and enables more effective long-term treatment planning, especially in complex forms of liver tumors.

Share:

Related posts

First pulmonary cryoablation at Tartu University Hospital

The first pulmonary cryoablation procedure was successfully performed at Tartu University Hospital. This move strengthens the development of interventional oncology services in the region and provides more minimally invasive treatment options for patients with lung tumors.

Minimally Invasive Liver Cancer Treatment in Klaipeda

At Klaipėda University Hospital, a 70-year-old liver cancer patient who could not undergo surgery was given a minimally invasive treatment method – microwave ablation. During the procedure, the tumor is destroyed by precise exposure to heat, without damaging the surrounding tissues, and the patient’s recovery is faster and easier than after open surgery.

Interventional oncology and advances in liver cancer treatment.

The session held at the University Hospital of Tartu discussed the importance of interventional oncology in the treatment of liver cancer, emphasizing the importance of multidisciplinary collaboration, innovative technologies such as AI-based planning, and economically sustainable solutions to ensure more accurate, effective and patient-tailored treatment.

International cooperation strengthens the advancement of CTO treatment.

The 17th CTO Days conference in Riga brought together interventional cardiology specialists from different countries for a joint analysis and exchange of experience in the treatment of complex chronic coronary artery blockages (CTOs). The program focuses on real-time procedure monitoring, clinical case analysis, and discussion of technical solutions. Such conferences directly contribute to the improvement of clinical practice and the improvement of the quality of patient care.